These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31960496)

  • 41. Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study.
    Uchida H; Kamata M; Mizukawa I; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Br J Dermatol; 2019 Nov; 181(5):1083-1085. PubMed ID: 31127860
    [No Abstract]   [Full Text] [Related]  

  • 42. Dupilumab improved atypical fibrotic skin plaques in atopic dermatitis.
    Nakashima C; Ishida Y; Kaku Y; Epstein EH; Otsuka A; Kabashima K
    Br J Dermatol; 2020 Feb; 182(2):487-488. PubMed ID: 31325158
    [No Abstract]   [Full Text] [Related]  

  • 43. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review.
    Napolitano M; Nocerino M; Picone V; Martora F; Fabbrocini G; Dastoli S; Patruno C
    Dermatol Ther; 2022 Apr; 35(4):e15324. PubMed ID: 35048522
    [No Abstract]   [Full Text] [Related]  

  • 45. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
    Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
    Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
    [No Abstract]   [Full Text] [Related]  

  • 46. The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: a case series of seven patients.
    Harada K; Irisawa R; Ito T; Uchiyama M; Tsuboi R
    Br J Dermatol; 2020 Aug; 183(2):396-397. PubMed ID: 32118289
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
    Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
    J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.
    Hansel K; Patruno C; Antonelli E; Dal Bello G; Napolitano M; Fabbrocini G; Grieco T; Pellacani G; Fargnoli MC; Esposito M; Piras V; Zucca M; Girolomoni G; Stingeni L
    Clin Exp Dermatol; 2022 Jan; 47(1):165-167. PubMed ID: 34309892
    [No Abstract]   [Full Text] [Related]  

  • 49. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?
    Pistone G; Tilotta G; Gurreri R; Castelli E; Curiale S; Bongiorno MR
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e255-e256. PubMed ID: 31985084
    [No Abstract]   [Full Text] [Related]  

  • 51. A case of Atopic dermatitis and Hidradenitis Suppurativa successfully treated with Dupilumab.
    Gambardella A; Calabrese G; Di Brizzi EV; Alfano R; Argenziano G
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e284-e286. PubMed ID: 32034813
    [No Abstract]   [Full Text] [Related]  

  • 52. Exacerbation of psoriasis after initiation of dupilumab in atopic dermatitis patient.
    Dimitrov D; Al Adawi M; Abdelhadi Z; Jafferany M
    Dermatol Ther; 2020 Jul; 33(4):e13572. PubMed ID: 32406135
    [No Abstract]   [Full Text] [Related]  

  • 53. Alopecia areata development in atopic dermatitis patients treated with dupilumab.
    Ständer S; Trense Y; Thaçi D; Ludwig RJ
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e612-e613. PubMed ID: 32311803
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
    Oosterhaven JAF; Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
    J Dermatol; 2019 Aug; 46(8):680-685. PubMed ID: 31187925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effective treatment of atopic dermatitis with dupilumab in an HIV-positive patient.
    Olbricht N; Kromer C; Forkel S; Schön MP; Buhl T
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1488-1490. PubMed ID: 32909372
    [No Abstract]   [Full Text] [Related]  

  • 56. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany.
    Abraham S; Haufe E; Harder I; Heratizadeh A; Kleinheinz A; Wollenberg A; Weisshaar E; Augustin M; Wiemers F; Zink A; Biedermann T; von Kiedrowski R; Hilgers M; Worm M; Pawlak M; Sticherling M; Fell I; Handrick C; Schäkel K; Staubach P; Asmussen A; Schwarz B; Bell M; Neubert K; Effendy I; Bieber T; Homey B; Gerlach B; Tchitcherina E; Stahl M; Schwichtenberg U; Rossbacher J; Buck P; Mempel M; Beissert S; Werfel T; Weidinger S; Schmitt J;
    Br J Dermatol; 2020 Aug; 183(2):382-384. PubMed ID: 32068242
    [No Abstract]   [Full Text] [Related]  

  • 58. Dupilumab as treatment for atopic dermatitis in a pediatric heart transplant patient: A case report.
    Jamgochian M; Milgraum D; Milgraum S; Pappert A
    Dermatol Ther; 2020 Nov; 33(6):e14018. PubMed ID: 32672892
    [No Abstract]   [Full Text] [Related]  

  • 59. Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients.
    Wang Y; Jorizzo J
    Int J Dermatol; 2021 Sep; 60(9):e382. PubMed ID: 33715168
    [No Abstract]   [Full Text] [Related]  

  • 60. Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment.
    Napolitano M; Caiazzo G; Fabbrocini G; Balato A; Di Caprio R; Scala E; Scalvenzi M; Patruno C
    Br J Dermatol; 2021 Feb; 184(2):341-343. PubMed ID: 33533476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.